Diabetes drug tested to fight weight gain from HIV meds
NCT ID NCT07336797
Summary
This study is testing if a drug called empagliflozin, usually used for diabetes, can help control weight gain and improve heart health in people living with HIV. It will involve 66 adults with HIV who are overweight and on a specific antiviral treatment. Researchers will measure changes in weight, cholesterol, blood sugar, and blood pressure over six months to see if the drug helps manage these common side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV (HUMAN IMMUNODEFICIENCY VIRUS) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Faculty of Pharmacy, Cairo University | Kasr El-Aini, Cairo
RECRUITINGCairo, 11562, Egypt
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.